SYSTEMATIC REVIEW AND META-ANALYSIS OF BRIAKINUMAB, A FULLY HUMAN INTERLEUKIN 12/23 MONOCLONAL ANTIBODY, FOR THE TREATMENT OF MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS

被引：0
|
作者：
Vsn, M.
Mothe, R. K.
Hyderboini, R. K.
Likhar, N.
Ganji, K.
Singuru, S.
Dang, A.
机构：
[1] MarksMan Healthcare Solut LLP, Hlth Econ & Outcomes Res HEOR, Navi Mumbai, India
[2] RWE, Navi Mumbai, India
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.494
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS5
引用
收藏
页码：A123 / A123
页数：1
相关论文
共 50 条
  • [31] Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis
    April Armstrong
    Kyle Fahrbach
    Craig Leonardi
    Matthias Augustin
    Binod Neupane
    Paulina Kazmierska
    Marissa Betts
    Andreas Freitag
    Sandeep Kiri
    Vanessa Taieb
    Mahmoud Slim
    Natalie Nunez Gomez
    Richard B. Warren
    Dermatology and Therapy, 2022, 12 : 1777 - 1792
  • [32] Treatment of plaque psoriasis with IL-23p19 blockers: A systematic review and meta-analysis
    Xu, Shanshan
    Zhang, Xiaoyi
    Pan, Meijuan
    Shuai, Zongwen
    Xu, Shengqian
    Pan, Faming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 75
  • [33] COMPARATIVE EFFICACY OF BIMEKIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS: A NETWORK META-ANALYSIS
    Armstrong, A.
    Reich, K.
    Warren, R. B.
    Taieb, V
    Fahrbach, K.
    Kazmierska, P.
    Betts, M.
    Neupane, B.
    Kiri, S.
    Gordon, K.
    VALUE IN HEALTH, 2021, 24 : S14 - S14
  • [34] Efficacy and safety of Risankizumab in moderate to severe psoriasis: A systematic review and meta-analysis
    Singh, Surjit
    Singh, Saurabh
    Thangaswamy, Abisha
    Thangaraju, Pugazhenthan
    Varthya, Shoban Babu
    DERMATOLOGIC THERAPY, 2021, 34 (01)
  • [35] Efficacy and Safety of Interleukin-12, 23 Inhibitors vs Interleukin-23 inhibitors for Moderate to Severe Ulcerative Colitis: A Systematic Review and Network Meta-Analysis
    Pasam, Ravi Teja
    Gautam, Misha
    Venugopalan, Sruthi
    Mohan, Babu
    Navaneethan, Udaykumar
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S833 - S834
  • [36] A network meta-analysis for the comparison of efficacy and safety of interleukin (IL)-23 targeted drugs in the treatment of moderate to severe psoriasis
    Shi, Jianzhen
    Xu, Jianru
    Chen, Yanmei
    DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [37] Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta-analysis
    Hu, Caixia
    Han, Xiaomei
    Cui, Yu
    Zhang, Yan
    Cheng, Yi
    SKIN RESEARCH AND TECHNOLOGY, 2024, 30 (08)
  • [38] Efficacy and safety of tofacitinib for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials
    Kuo, C. -M.
    Tung, T. -H.
    Wang, S. -H.
    Chi, C. -C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 355 - 362
  • [39] Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: a meta-analysis of randomized clinical trials
    Wang, Yuqian
    Li, Sheng
    Bai, Juan
    Cai, Xiaoxuan
    Tang, Shunli
    Lin, Peiyi
    Sun, Qingmiao
    Qiao, Jianjun
    Fang, Hong
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2023, 14
  • [40] Anti-interleukin 5 treatment in moderate to severe eosinophilic chronic obstructive pulmonary disease: a systematic review and meta-analysis
    Rosellen Tan, Irene
    Elvi Villalobos, Ralph
    May Jaen, Anjuli
    David-Wang, Aileen
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345